Nonsyndromic deafness

Source: Wikipedia, the free encyclopedia.
Nonsyndromic deafness
Other namesNon-syndromic genetic deafness
Treatmentvancomycin

Nonsyndromic deafness is

mitochondrial inheritance.[1][2]

Genetic changes are related to the following types of nonsyndromic deafness:

Each type is numbered in the order in which it was described. For example, DFNA1 was the first described autosomal dominant type of nonsyndromic deafness. Mitochondrial nonsyndromic deafness involves changes to the small amount of DNA found in mitochondria, the energy-producing centers within cells.[3]

Most forms of nonsyndromic deafness are associated with permanent hearing loss caused by damage to structures in the inner ear. The inner ear consists of three parts: a snail-shaped structure called the cochlea that helps process sound, nerves that send information from the cochlea to the brain, and structures involved with balance. Loss of hearing caused by changes in the inner ear is called sensorineural deafness. Hearing loss that results from changes in the middle ear is called conductive hearing loss. The middle ear contains three tiny bones that help transfer sound from the eardrum to the inner ear. Some forms of nonsyndromic deafness involve changes in both the inner ear and the middle ear; this combination is called mixed hearing loss.

The severity of hearing loss varies and can change over time. It can affect one ear (unilateral) or both ears (bilateral). Degrees of hearing loss range from mild (difficulty understanding soft speech) to profound (inability to hear even very loud noises). The loss may be stable, or it may progress as a person gets older. Particular types of nonsyndromic deafness often show distinctive patterns of hearing loss. For example, the loss may be more pronounced at high, middle, or low tones.

Classification

Nonsyndromic deafness can occur at any age. Hearing loss that is present before a child learns to speak is classified as prelingual or congenital. Hearing loss that occurs after the development of speech is classified as postlingual.

Genetics

Nonsyndromic deafness can have different patterns of inheritance. Between 75% and 80% of cases are inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered. Usually, each parent of an individual with autosomal recessive deafness is a carrier of one copy of the altered gene. These carriers do not have hearing loss.

Another 20% to 25% of nonsyndromic deafness cases are autosomal dominant, which means one copy of the altered gene in each cell is sufficient to result in hearing loss. People with autosomal dominant deafness most often inherit an altered copy of the gene from a parent who has hearing loss.

Between 1% and 2% of cases show an X-linked pattern of inheritance, which means the mutated gene responsible for the condition is located on the X chromosome. Males with X-linked nonsyndromic deafness tend to develop more severe hearing loss earlier in life than females who inherit a copy of the same gene mutation. Fathers will not pass X-linked traits to their sons since they do not pass on the X chromosome to their male offspring.

Mitochondrial nonsyndromic deafness, which results from changes to the DNA in mitochondria, occurs in fewer than 1% of cases in the United States. The altered mitochondrial DNA is passed from a mother to her sons and daughters. This type of deafness is not inherited from fathers.

Late onset progressive deafness is the most common neurological disability of the elderly. Although hearing loss of greater than 25 decibels is present in only 1% of young adults between the ages of 18 and 24 years of age, this increases to 10% in persons between 55 and 64 years of age and approximately 50% in octogenarians.

The relative contribution of heredity to age-related hearing impairment is not known, however the majority of inherited late-onset deafness is autosomal dominant and non-syndromic (Van Camp et al., 1997). Over forty genes associated with autosomal dominant non-syndromic hearing loss have been localized and of these fifteen have been cloned.

Genes related to nonsyndromic deafness

Mutations in the

SLC26A5, and WHRN
.

The causes of nonsyndromic deafness can be complex. Researchers have identified more than 30 genes that, when mutated, may cause nonsyndromic deafness; however, some of these genes have not been fully characterized. Many genes related to deafness are involved in the development and function of the inner ear. Gene mutations interfere with critical steps in processing sound, resulting in hearing loss. Different mutations in the same gene can cause different types of hearing loss, and some genes are associated with both syndromic and nonsyndromic deafness.

In many families
, the gene(s) involved have yet to be identified.

Deafness can also result from environmental factors or a combination of genetic and

environmental
factors, including certain medications, peri-natal infections (infections occurring before or after birth), and exposure to loud noise over an extended period.

Types include:

OMIM
Gene Type
124900 DIAPH1 DFNA1
600101 KCNQ4 DFNA2A
612644 GJB3 DFNA2B
601544 GJB2 DFNA3A
612643 GJB6 DFNA3B
600652 MYH14 DFNA4
600994 DFNA5 DFNA5
601543 TECTA DFNA8/12
601369
COCH
DFNA9
601316
EYA4
DFNA10
601317 MYO7A DFNA11, neurosensory
601868
COL11A2
DFNA13
602459 POU4F3 DFNA15
603622 MYH9 DFNA17
604717
ACTG1
DFNA20/26
606346
MYO6
DFNA22
605192
SIX1
DFNA23
605583
SLC17A8
DFNA25
608641
GRHL2
DFNA28
606705 TMC1 DFNA36
605594
DSPP
DFNA36, with dentinogenesis
607453 CCDC50 DFNA44
607841
MYO1A
DFNA48
613074 MIR96 DFNA50
220290 GJB2 DFNB1A
612645 GJB6 DFNB1B
600060 MYO7A DFNB2, neurosensory (see also Usher syndrome)
600316 MYO15A DFNB3
600971 TMIE DFNB6
600974 TMC1 DFNB7
601072 TMPRSS3 DFNB8, childhood onset
601071
OTOF
DFNB9
601386 CDH23 DFNB12
603720 STRC DFNB16
602092 USH1C DFNB18
603629 TECTA DFNB21
607039
OTOA
DFNB22
609533 PCDH15 DFNB23
611022 RDX DFNB24
613285 GRXCR1 DFNB25
609823 TRIOBP DFNB28
614035 CLDN14 DFNB29
607101
MYO3A
DFNB30
607084 WHRN DFNB31
608565
ESRRB
DFNB35
609006 ESPN DFNB36
607821
MYO6
DFNB37
608265 HGF DFNB39
610153 MARVELD2 DFNB49
609706
COL11A2
DFNB53
610220
PJVK
DFNB59
611451 LRTOMT DFNB63
610265 LHFPL5 DFNB67
613079 LOXHD1 DFNB77
613307 TPRN DFNB79
613391
PTPRQ
DFNB84
613453 SERPINB6 DFNB91
614899
CABP2
DFNB93
304500
PRPS1
DFNX1
304400 POU3F4 DFNX2
580000 MT-RNR1, COX1[4] deafness, aminoglycoside-induced
500008 (several mtDNA) DFN, sensorineural, mt

Diagnosis

The diagnosis of nonsyndromic deafness involves a comprehensive assessment to determine the cause of hearing loss in an individual without associated syndromic features. Key steps in the diagnosis may include:

In some cases, other methods may be conducted, including imaging techniques such as

auditory nerve. Screening blood tests for metabolic conditions or infections that could contribute to hearing loss may also be recommended.[9][10]

Treatment

Treatment is supportive and consists of management of- manifestations. Use of hearing aids and/or cochlear implant, suitable educational programs can be offered. Periodic surveillance is also important.[11]

Epidemiology

About 1 in 1,000 children in the United States is born with profound deafness. By age 9, about 3 in 1,000 children have hearing loss that affects the activities of daily living. More than half of these cases are caused by genetic factors. Most cases of genetic deafness (70% to 80%) are nonsyndromic; the remaining cases are caused by specific genetic syndromes. In adults, the chance of developing hearing loss increases with age; hearing loss affects half of all people older than 80 years.

References

  1. S2CID 19240967
    .
  2. .
  3. ^ Reference, Genetics Home. "nonsyndromic hearing loss". Genetics Home Reference. Retrieved 14 April 2017.
  4. PMID 20301595. {{cite journal}}: Cite journal requires |journal= (help
    )
  5. .
  6. .
  7. .
  8. .
  9. .
  10. .
  11. .

Further reading

External links